Healthcare Radiopharmaceuticals Workshop 
Imaging Technology
JUNE 15, 2023
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use. Lancet Oncology 2023; 24(3): e133-e143.
Imaging Technology
NOVEMBER 2, 2023
milla1cf Thu, 11/02/2023 - 13:52 November 2, 2023 — GE HealthCare’s Artificial Intelligence ( AI ) models predict patient response to immunotherapies with 70 to 80 percent accuracy [1] , based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer ( SITC ) in San Diego, U.S., 3] Shankar L.
Imaging Technology
MAY 17, 2024
or with virtual access to livestreams of all scientific and educational sessions.
Expert insights. Personalized for you.
98 
Let's personalize your content